Advertisement

Topics

Less Is More: FDA May Narrow Risk Info In Rx Drug TV Ads

10:49 EDT 19 Aug 2017 | SCRIP

Agency is considering whether drug broadcast ads should note only risks that are severe, serious or actionable; FDA study finds...

      

Related Stories

 

Original Article: Less Is More: FDA May Narrow Risk Info In Rx Drug TV Ads

NEXT ARTICLE

More From BioPortfolio on "Less Is More: FDA May Narrow Risk Info In Rx Drug TV Ads"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...